Monday, November 25, 2024
HomeTagsCharles Morris

Charles Morris

Celyad Oncology Announces FDA Lifts Clinical Hold of CYAD-101-002 Phase 1b Trial

Celyad Oncology SA, a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics